Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Aug;25(2):658–663. doi: 10.1128/iai.25.2.658-663.1979

Interferon production: variation in yields from human cell lines.

A Meager, H E Graves, J Shuttleworth, N Zucker
PMCID: PMC414495  PMID: 489124

Abstract

A survey of human diploid, aneusomic, transformed and tumor fibroblast or fibroblastoid cell lines for their capacity to produce interferon after polyriboinosinic acid:polycytidylic acid induction showed considerable variation in responsiveness. There was no apparent correlation between karyotype or phenotype and interferon production. Pretreating or "priming" the cells with human interferon generally led to increased yields of interferon after polyriboinosinic acid:polycytidylic acid induction in all cell lines tested. All the cells also showed the "super-induction" phenomenon, although to varying degrees. The combination of priming and superinduction conditions led to the production of very high yields of interferon in some cell lines, but in other lines, yields less than either the primed or superinduced amounts were found. A more limited survey of human cell lines for their capacity to produce interferon after Newcastle disease virus induction also showed that yields varied from line to line. However, there was little evidence to suggest that ability to produce interferon after Newcastle disease virus induction correlated with that after polyriboinosinic acid:polycytidylic acid induction.

Full text

PDF
658

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvin A. M., Yeager A. S., Merigan T. C. Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants. J Infect Dis. 1976 Jun;133 (Suppl):A205–A210. doi: 10.1093/infdis/133.supplement_2.a205. [DOI] [PubMed] [Google Scholar]
  2. Atherton K. T., Burke D. C. Interferon induction by viruses and polynucleotides: a differential effect of comptothecin. J Gen Virol. 1975 Dec;29(3):297–304. doi: 10.1099/0022-1317-29-3-297. [DOI] [PubMed] [Google Scholar]
  3. Billiau A., Edy V. G., Heremans H., Van Damme J., Desmyter J., Georgiades J. A., De Somer P. Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother. 1977 Jul;12(1):11–15. doi: 10.1128/aac.12.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Billiau A., Joniau M., De Somer P. Mass production of human interferon in diploid cells stimulated by poly-I:C. J Gen Virol. 1973 Apr;19(1):1–8. doi: 10.1099/0022-1317-19-1-1. [DOI] [PubMed] [Google Scholar]
  5. Billiau A., Joniau M., De Somer P. Production of crude human interferon with high specific activity. Proc Soc Exp Biol Med. 1972 Jun;140(2):485–491. doi: 10.3181/00379727-140-36486. [DOI] [PubMed] [Google Scholar]
  6. Blomgren H., Cantell K., Johansson B., Lagergren C., Ringborg U., Strander H. Interferon therapy in Hodgkin's disease. A case report. Acta Med Scand. 1976;199(6):527–532. doi: 10.1111/j.0954-6820.1976.tb06776.x. [DOI] [PubMed] [Google Scholar]
  7. De Clercq E., Edy V. G., De Vlieger H., Eeckels R., Desmyter J. Intrathecal administration of interferon in neonatal herpes. J Pediatr. 1975 May;86(5):736–739. doi: 10.1016/s0022-3476(75)80360-x. [DOI] [PubMed] [Google Scholar]
  8. Desmyter J., De Groote J., Desmet V. J., Billiau A., Ray M. B., Bradburne A. F., Edy V. G., De Somer P. Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet. 1976 Sep 25;2(7987):645–647. doi: 10.1016/s0140-6736(76)92460-0. [DOI] [PubMed] [Google Scholar]
  9. Greenberg H. B., Pollard R. B., Lutwick L. I., Gregory P. B., Robinson W. S., Merigan T. C. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976 Sep 2;295(10):517–522. doi: 10.1056/NEJM197609022951001. [DOI] [PubMed] [Google Scholar]
  10. Hackett A. J., Smith H. S., Springer E. L., Owens R. B., Nelson-Rees W. A., Riggs J. L., Gardner M. B. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst. 1977 Jun;58(6):1795–1806. doi: 10.1093/jnci/58.6.1795. [DOI] [PubMed] [Google Scholar]
  11. Havell E. A., Vilcek J. Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother. 1972 Dec;2(6):476–484. doi: 10.1128/aac.2.6.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Horoszewicz J. S., Leong S. S., Ito M., Di Berardino L., Carter W. A. Aging in vitro and large-scale interferon production by 15 new strains of human diploid fibroblasts. Infect Immun. 1978 Feb;19(2):720–726. doi: 10.1128/iai.19.2.720-726.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Larsson A., Forsgren M., Hård af Segerstad S., Strander H., Cantell K. Administration of interferon to an infant with congenital rubella syndrome involving persistent viremia and cutaneous vasculitis. Acta Paediatr Scand. 1976 Jan;65(1):105–110. doi: 10.1111/j.1651-2227.1976.tb04415.x. [DOI] [PubMed] [Google Scholar]
  14. Lomniczi B., Meager A., Burke D. C. Virus RNA and protein synthesis in cells infected with different strains of Newcastle disease virus. J Gen Virol. 1971 Oct;13(1):111–120. doi: 10.1099/0022-1317-13-1-111. [DOI] [PubMed] [Google Scholar]
  15. Lomniczi B. Systemic induction of interferon in chicks with various NDV strains. I. Relationship between virulence of the virus and the mechanism of interferon production. Arch Gesamte Virusforsch. 1970;30(2):159–166. doi: 10.1007/BF01250184. [DOI] [PubMed] [Google Scholar]
  16. McWilliams M., Finkelstein M. S., Allen P. T., Giron D. J. Assay of chick interferons by the inhibition of viral ribonucleic acid synthesis. Appl Microbiol. 1971 May;21(5):959–961. doi: 10.1128/am.21.5.959-961.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Meager A., Graves H. E., Bradshaw T. K. Stimulation of interferon yields from cultured human cells by calcium salts. FEBS Lett. 1978 Mar 15;87(2):303–307. doi: 10.1016/0014-5793(78)80356-1. [DOI] [PubMed] [Google Scholar]
  18. Rosenberg N., Schaeffer W. I., Diamond L. Isolation of variant cells from SV-40 transformed human diploid fibroblasts. Cancer Res. 1975 Aug;35(8):1970–1974. [PubMed] [Google Scholar]
  19. Rosztóczy I., Mécs I. Enhancement of interferon synthesis by polyinosinic-polycytidylic acid in L cells pretreated with interferon. Acta Virol. 1970 Sep;14(5):398–400. [PubMed] [Google Scholar]
  20. Stewart W. E., 2nd, Gosser L. B., Lockart R. Z., Jr Priming: a nonantiviral function of interferon. J Virol. 1971 Jun;7(6):792–801. doi: 10.1128/jvi.7.6.792-801.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Strander H., Cantell K., Carlström G., Ingimarsson S., Jakobsson P., Nilsonne U. Acute infections in interferon-treated patients with osteosarcoma: preliminary report of a comparative study. J Infect Dis. 1976 Jun;133 (Suppl):A245–A248. doi: 10.1093/infdis/133.supplement_2.a245. [DOI] [PubMed] [Google Scholar]
  22. Strander H., Cantell K., Carlström G., Jakobsson P. A. Clinical and laboratory investigations on man: systemic administration of potent interferon to man. J Natl Cancer Inst. 1973 Sep;51(3):733–742. doi: 10.1093/jnci/51.3.733. [DOI] [PubMed] [Google Scholar]
  23. Tan Y. H., Armstrong J. A., Ke Y. H., Ho M. Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A. 1970 Sep;67(1):464–471. doi: 10.1073/pnas.67.1.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tan Y. H., Berthold W. A mechanism for the induction and regulation of human fibroblastoid interferon genetic expression. J Gen Virol. 1977 Mar;34(3):401–411. doi: 10.1099/0022-1317-34-3-401. [DOI] [PubMed] [Google Scholar]
  25. Walters S., Burke D. C., Skehel J. J. Interferon production and RNA inhibitors. J Gen Virol. 1967 Jul;1(3):349–362. doi: 10.1099/0022-1317-1-3-349. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES